Table 1.
Patients | ||||||
Controls | Placebo | 25 µg Clonidine | 50 µg Clonidine | 75 µg Clonidine | 150 µg Clonidine | |
Mean age (SEM) | 36.5 y (1.5) | 37.5 y (1.4) | ||||
Average PANSS scores (SEM) | ||||||
Positive | 13.0 (1.2) | 14.0 (1.6) | 12.7 (1.1) | 13.8 (1.6) | 12.5 (0.9) | |
Negative | 14.3 (1.2) | 15.6 (1.0) | 15.4 (1.4) | 15.4 (1.2) | 14.3 (1.1) | |
General | 25.4 (1.6) | 27.1 (1.9) | 25.1 (1.7) | 25.7 (1.6) | 24.4 (1.2) | |
Total | 52.6 (3.4) | 56.1 (3.4) | 53.1 (3.4) | 54.8 (3.9) | 50.8 (2.4) |
Note: Characteristics of patients and matched healthy controls, showing no significant differences in age between patients and controls, nor significant differences in PANSS scores in the patients over the 5 different test sessions.